Consensus on management of children with cancer, neutropenia and fever. Update 2008-2009;Consenso sobre el cuidado del paciente oncológico neutropénico febril. Actualización 2008-2009

Archivos Argentinos de Pediatria

Volumn 108, Issue 2, 2010, Pages

  Del Pont, José Marcó ^a   Casanueva, Enrique ^b   Aguirre, Clarisa ^c   Bogdanowicz, Elizabeth ^d   Bazán, Virgina ^e   Caruso, Martín ^f   Della Latta, María Paula ^g   Ensink, Gabriela ^h   Epelbaum, Carolina ^g   Fallo, Aurelia ^e   Firpo, Verónica ⁱ   Flynn, Luis ^j   Gane, Andrea Gajo ^c   Gentile, Ángela ^e   Gómez, Sandra ^g   Papucci, Santiago López ^h   Mengual, Marcela ^g   Miranda, María Rosa ^f   Brieschke, María Teresa Rodríguez ^k   Sarkis, Claudia ^g   Tonetto, Ivana ^a   Vilches, Viviana ^l   Vina, Analía ^e   more..

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^b Hospital de Ninos de San Justo   (Argentina)

^c Hospital Pediatrico Juan Pablo II   (Argentina)

^d Hospital de Clínicas   (Argentina)

^e Hospital de Niños Dr R Gutiérrez   (Argentina)

^f Hospital de Niños Héctor Quintana de Jujuy   (Argentina)

^g HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^h Hospital de Ninõs Víctor Vilela Rosario   (Argentina)

ⁱ Hospital Niño Jesús de Tucumán   (Argentina)

^j Jefe de la Unidad de Quemados y Servicio de Cirugía Plástica y Reconstructiva del Hospital de Niños V J Vilela   (Argentina)

^k Hospital General de Agudos F Santojani   (Argentina)

^l UNIVERSIDAD AUSTRAL   (Argentina)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; AMPICILLIN; ANTIBIOTIC AGENT; CEFEPIME; CEFIXIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; FLUCONAZOLE; GANCICLOVIR; GENTAMICIN; IMIPENEM; ITRACONAZOLE; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; UNINDEXED DRUG; VACCINE; VALGANCICLOVIR; VANCOMYCIN;

ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; ASPERGILLUS; BACTEREMIA; BACTERIAL INFECTION; CANDIDA; CHILD; CHILDHOOD CANCER; CONFERENCE PAPER; CONSENSUS; FEBRILE NEUTROPENIA; HUMAN; IMMUNIZATION; INFECTION RISK; MORBIDITY; MORTALITY; MYCOSIS; NEUTROPHIL COUNT; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TOXOPLASMA GONDII; TREATMENT DURATION; VIRUS INFECTION;

CHILD; FEVER; HUMANS; INFECTION; NEOPLASMS; NEUTROPENIA;

EID: 77952532966     PISSN: 03250075     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (47)

1. nd ed. Nueva York: Plenum Medical; 1988. Págs.433-66.
2. Pizzo PA, Robichaud KJ, Wesley R, et al. Fever in the pediatric and young patients with cancer: a prospective study of 1001 episodes. Medicine 1982;61:153-165. (Pubitemid 12073571)
3. Urabe A. Clinical features of the neutropenic host: definitions and initial evaluation. Clin Infect Dis 2004;39:S53-55.
4. Bodey GP, Buckley M, Sathe YS, et al. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966;64:328-340
5. Santolaya ME, Álvarez A, Avilés C, et al. Admision clinical and laboratory factors associated with death in children with cancer during a febrile neutropenic episode. Ped Infec Dis J 2007;26(9):794-798. (Pubitemid 47329849)
6. Santolaya ME, Álvarez AM, Becker A, et al. Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia and fever. J Clin Oncol 2001;19:3415-3421. (Pubitemid 32642195)
7. Santolaya ME, Álvarez A, Avilés CL, et al. Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever and neutropenia. Clin Infect Dis 2002;35:678-683
8. Paganini H, Rodríguez Brieschcke T, et al. Criterios de riesgo de mortalidad en niños con neutropenia y fiebre durante la quimioterapia por cáncer. Medicina (Buenos Aires) 2001;61:63-66. (Pubitemid 32224365)
9. Comité Nacional de Infectología de la Sociedad Argentina de Pediatría. Consenso Nacional. Riesgo de infección en el paciente oncológico. Arch Argent Pediatr 2003;101-4:270-295.
10. Viscoli C, Verniet O, Machetti M. Infections in patients with febrile neutropenia: epidemiology, microbiology and risk stratification. Clin Infect Dis 2005;40:s240-5.
11. Guías de Recomendaciones sobre Diagnóstico, Tratamiento y Prevención de Infecciones en Pacientes con Cáncer. Consenso de la Sociedad Argentina de Infectología. Comisión de Infecciones en el Paciente Neoplásico y Trasplantado de Médula Ósea. 2006.
12. Ramphal R. Changes in the etiology of bacteriemia in febril neutropenic patients and the susceptibilities range of the currently isolated pathogens. Clin Infect Dis 2004;39:s25.
13. Wingard JR, Merz WG, Rinaldi MG, et al. Increase in Can dida Krusei infection among patient with marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991;325:1274-1277
14. as Jornadas Del Grupo Rioplatense de Citometría de Flujo. Mar de Plata, Argentina. 31 de octubre al 3 de Noviembre de 2001.
15. IDSA Guidelines for treatment of candidiasis. CID 2004:38(15 january)161-181.
16. Picazzo J. Management of the febrile neutropenic patient: a consensus conference. Clin Infect Dis 2004;39:s1-6.
17. Bodey GP. Managing infections in the immunocompromised patient. Clin Infect Dis 2005;40:239.
18. Santolaya ME, Rabagliati R, Bidart T, et al. Consenso de manejo racional del paciente con cáncer, neutropenia y fiebre. Rev Chil Infect 2005;22:s79-111.
19. Comité Nacional de Infectología Pediátrica. Sociedad Argentina de Pediatría. Neutropenia y fiebre. Libro Azul de Infectología Pediátrica. Capítulo 25, Buenos Aires: FUNDASAP Ediciones; 2007. Págs.245-258.
20. Jarque I, Salavert M, Sanz M. Manejo del paciente neutropénico con fiebre. Enferm Infecc Microbiol Clín 2005;23(supl5): 24-29. (Pubitemid 47398757)
21. De Cicco L, Marcó del Pont J, Frangi F, Dibar E. Valor de la proteína C reactiva (PCR) en la evaluación del paciente oncológico con neutropenia y fiebre. 32° Congreso Argentino de Pediatría. 27 al 30 de septiembre, 2000. Salta, Argentina.
22. Hughes W, Armstrong D, Bodey G, et al. Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34:730-751 (Pubitemid 34194843)
23. Rolston KV. The infectious diseases society of America 2002. Guidelines for the use of antimicrobial agents in patients with cancer and neutropenia: salient features and comments. Clin Infect Dis 2004;39:544-548
24. Rolston KV. Challenges in the treatment of infections caused by gram-positive and gram-negative bacteria in patients with cancer and neutropenia. Clin Infect Dis 2005;40:5246-5252
25. Pizzo PA. Management of fever in patients with cancer and treatment induce neutropenia. N Engl J Med 1993;328:1323-1332.
26. Santolaya ME, Álvarez AM, Avilés CL, et al. Early hospital discharge followed by outpatient management versus continued hospitalizations of children with cancer, fever and neutropenia at low risk for invasive bacterial infection. J Clin Oncol 2004;22:3784-3789.
27. Marcó del Pont J, De Cicco L, Frangi F, et al. Nuevas modalidades terapéuticas en el manejo del paciente neutropénico y febril pediátrico. 32° Congreso Argentino de Pediatría. 27 al 30 de septiembre, 2000. Salta, Argentina.
28. Paganini H, Gómez S, Ruvinsky S, et al. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk Febrile Neutropenia in children with malignant disease. Cáncer 2003;97:2493.
29. Freifeld A, Marchigiani D, Walsh T, et al. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemoterapy. N Engl J Med 1999;341-5-11.
30. Tonetto I, Posse V, Marcó del Pont J, Rocha E, Martini V. Experiencia de un Hospital de Comunidad en el manejo antibiótico de los pacientes con neutropenia y fiebre. Sección de Infectología Pediátrica. Htal. Italiano. 6° Congreso Argentino de Infectología Pediátrica. 16-19 de abril de 2008. SAP. Buenos Aires, Argentina.
31. Oliveira AL, de Souza M, Carvalho-Dias VM. Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2007;39:775-781 (Pubitemid 46901976)
32. Steinbach WJ. Antifungal agents in children. Pediatr Clin N Am 2005; 52:895-915.
33. IDSA Guidelines for treatment of candidiasis. CID 2004:38(15 January)161-181.
34. Segal BH, Bow EJ, Menichetti F. Fungal infections in non-trasplant patients with hematologic malignancies. Inf Dis Clin North Am 2002;16:935-964. (Pubitemid 35477520)
35. Steinbach WJ, Addison RM, McLaughlin L, et al. Prospective Aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients. Pediatr Infect Dis J 2007;26(7):558-564 (Pubitemid 47014154)
36. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR. October 20, 2000/49(RR10);1-128.
37. Sandherr M, Einsele H, Hebart H, et al. Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the infectious diseases working party (AGIHO) of the German society for Hematology and Oncology (DGHO). Ann Oncol 2006;17:1051-1059.
38. Rijners BJ, Verwaest C, Peetermans WE, et al. Difference in time to positivity of hub-blood versus nonhub-blood cultures is not useful for the diagnosis of catheter-related bloodstream infection in critically ill patients. Crit Care Med 2001;29:1399-1403 (Pubitemid 32641803)
39. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001;32:1249-1272 (Pubitemid 32405897)
40. Guidelines for the prevention of intravascular catheter-related infections. MMWR Recommendations and Reports. August 9, 2002/51(RR10);1-26.
41. Boyce JM, Pittet D. Healthcare Infection Control Practices Advisory Committee; HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Guidelines for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Am J Infect Control 2002; 30:S1-46.
42. CDC. Recommendations of the Advisory Committee on Immunization Practices (ACIP): General Recommendations on Immunization. MMWR 2002;51(RR-2):22-24
43. CDC. Recommendations of the Advisory Committee on Immunization Practices (ACIP): General Recommendations on Immunization. December 1, 2006;56(RR15):1-48.
44. American Academy of Pediatric. En: Pickering L. ed. Red Book: Seccion 1. Immunization in Special Clinical Circumstances. Report of the Committee on Infectious Diseases 27° ed. Elk Grove Village: American Academy of Pediatrics; 2006.
45. Immunization in the Immunocompromised host. Plotkin SA, Orenstein WA (eds.). Vaccine, 4° Ed. Filadelfia: WB Saunder; 2004.
46. Ljungman P, Aschan J, Bankholt L, et al. Immunity after allogenic stem cell transplantion; influence of conditioning, and graft-versus hots disease. Bone Marrow Transplant 2004;34:589-593.
47. Ljungman P, Engelhard D, de la Camara R, et al. Vaccination of stem cell transplant recipients recommendations of infectious. Diseases Working Party of the EBMT. Bone Marrow Transplant 2005;35:737-746.